Citigroup
INSY

Citigroup’s Insys Therapeutics, Inc. INSY Stock Holding History

Citigroup’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,400
Closed -$53K – 7933
2019
Q1 		$53K Buy
11,400
+8,700
+322% +$41.2K ﹤0.01% 6303
2018
Q4 		$9K Sell
2,700
-4,300
-61% -$29.9K ﹤0.01% 7223
2018
Q3 		$71K Sell
7,000
-8,400
-55% -$67K ﹤0.01% 6227
2018
Q2 		$111K Buy
15,400
+7,100
+86% +$49.5K ﹤0.01% 5625
2018
Q1 		$50K Buy
8,300
+5,300
+177% +$43.8K ﹤0.01% 6176
2017
Q4 		$29K Buy
3,000
+2,000
+200% +$13.1K ﹤0.01% 6535
2017
Q3 		$9K Sell
1,000
-13,400
-93% -$138K ﹤0.01% 6733
2017
Q2 		$182K Sell
14,400
-1,200
-8% -$14.2K ﹤0.01% 4891
2017
Q1 		$164K Sell
15,600
-37,600
-71% -$401K ﹤0.01% 4825
2016
Q4 		$489K Buy
53,200
+33,200
+166% +$375K ﹤0.01% 4399
2016
Q3 		$236K Buy
20,000
+6,000
+43% +$91.2K ﹤0.01% 4530
2016
Q2 		$181K Buy
14,000
+300
+2% +$4.37K ﹤0.01% 4589
2016
Q1 		$219K Buy
13,700
+1,600
+13% +$30.4K ﹤0.01% 5004
2015
Q4 		$346K Buy
12,100
+11,800
+3,933% +$327K ﹤0.01% 4242
2015
Q3 		$9K Buy
+300
New +$11K ﹤0.01% 6511

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citigroup's INSY Position: Q2 2019 in Review

Citigroup sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 9,423 shares — an estimated $44K sold.

Citigroup first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $894K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Citigroup reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Citigroup sold 9,423 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $44K.
  • Citigroup first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
  • Citigroup's Insys Therapeutics, Inc. position peaked at $894K in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.